IL6 and COVID-19: This is probably due to the increase in Ang II levels caused by the SARS-CoV-2 and ACE2 interaction itself, and/or the interconnection between the inflammation produced by high levels of IL-6 and other pro-inflammatory cytokines and the oxidative stress identified in COVID-19 patients, contributing to tissue damage.